• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biopharmaceutical Testing Services
1.2 Key Market Segments
1.2.1 Biopharmaceutical Testing Services Segment by Type
1.2.2 Biopharmaceutical Testing Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biopharmaceutical Testing Services Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biopharmaceutical Testing Services Market Competitive Landscape
3.1 Global Biopharmaceutical Testing Services Revenue Market Share by Company (2019-2024)
3.2 Biopharmaceutical Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Biopharmaceutical Testing Services Market Size Sites, Area Served, Product Type
3.4 Biopharmaceutical Testing Services Market Competitive Situation and Trends
3.4.1 Biopharmaceutical Testing Services Market Concentration Rate
3.4.2 Global 5 and 10 Largest Biopharmaceutical Testing Services Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Biopharmaceutical Testing Services Value Chain Analysis
4.1 Biopharmaceutical Testing Services Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Biopharmaceutical Testing Services Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biopharmaceutical Testing Services Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biopharmaceutical Testing Services Market Size Market Share by Type (2019-2024)
6.3 Global Biopharmaceutical Testing Services Market Size Growth Rate by Type (2019-2024)
7 Biopharmaceutical Testing Services Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biopharmaceutical Testing Services Market Size (M USD) by Application (2019-2024)
7.3 Global Biopharmaceutical Testing Services Market Size Growth Rate by Application (2019-2024)
8 Biopharmaceutical Testing Services Market Segmentation by Region
8.1 Global Biopharmaceutical Testing Services Market Size by Region
8.1.1 Global Biopharmaceutical Testing Services Market Size by Region
8.1.2 Global Biopharmaceutical Testing Services Market Size Market Share by Region
8.2 North America
8.2.1 North America Biopharmaceutical Testing Services Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biopharmaceutical Testing Services Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biopharmaceutical Testing Services Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biopharmaceutical Testing Services Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biopharmaceutical Testing Services Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Eurofins Scientific
9.1.1 Eurofins Scientific Biopharmaceutical Testing Services Basic Information
9.1.2 Eurofins Scientific Biopharmaceutical Testing Services Product Overview
9.1.3 Eurofins Scientific Biopharmaceutical Testing Services Product Market Performance
9.1.4 Eurofins Scientific Biopharmaceutical Testing Services SWOT Analysis
9.1.5 Eurofins Scientific Business Overview
9.1.6 Eurofins Scientific Recent Developments
9.2 SGS
9.2.1 SGS Biopharmaceutical Testing Services Basic Information
9.2.2 SGS Biopharmaceutical Testing Services Product Overview
9.2.3 SGS Biopharmaceutical Testing Services Product Market Performance
9.2.4 SGS Biopharmaceutical Testing Services SWOT Analysis
9.2.5 SGS Business Overview
9.2.6 SGS Recent Developments
9.3 Envigo
9.3.1 Envigo Biopharmaceutical Testing Services Basic Information
9.3.2 Envigo Biopharmaceutical Testing Services Product Overview
9.3.3 Envigo Biopharmaceutical Testing Services Product Market Performance
9.3.4 Envigo Biopharmaceutical Testing Services SWOT Analysis
9.3.5 Envigo Business Overview
9.3.6 Envigo Recent Developments
9.4 Exova Group
9.4.1 Exova Group Biopharmaceutical Testing Services Basic Information
9.4.2 Exova Group Biopharmaceutical Testing Services Product Overview
9.4.3 Exova Group Biopharmaceutical Testing Services Product Market Performance
9.4.4 Exova Group Business Overview
9.4.5 Exova Group Recent Developments
9.5 PPD Inc.
9.5.1 PPD Inc. Biopharmaceutical Testing Services Basic Information
9.5.2 PPD Inc. Biopharmaceutical Testing Services Product Overview
9.5.3 PPD Inc. Biopharmaceutical Testing Services Product Market Performance
9.5.4 PPD Inc. Business Overview
9.5.5 PPD Inc. Recent Developments
9.6 Pace Analytical Services
9.6.1 Pace Analytical Services Biopharmaceutical Testing Services Basic Information
9.6.2 Pace Analytical Services Biopharmaceutical Testing Services Product Overview
9.6.3 Pace Analytical Services Biopharmaceutical Testing Services Product Market Performance
9.6.4 Pace Analytical Services Business Overview
9.6.5 Pace Analytical Services Recent Developments
9.7 Intertek Group
9.7.1 Intertek Group Biopharmaceutical Testing Services Basic Information
9.7.2 Intertek Group Biopharmaceutical Testing Services Product Overview
9.7.3 Intertek Group Biopharmaceutical Testing Services Product Market Performance
9.7.4 Intertek Group Business Overview
9.7.5 Intertek Group Recent Developments
9.8 DYNALABS
9.8.1 DYNALABS Biopharmaceutical Testing Services Basic Information
9.8.2 DYNALABS Biopharmaceutical Testing Services Product Overview
9.8.3 DYNALABS Biopharmaceutical Testing Services Product Market Performance
9.8.4 DYNALABS Business Overview
9.8.5 DYNALABS Recent Developments
9.9 RD Laboratories
9.9.1 RD Laboratories Biopharmaceutical Testing Services Basic Information
9.9.2 RD Laboratories Biopharmaceutical Testing Services Product Overview
9.9.3 RD Laboratories Biopharmaceutical Testing Services Product Market Performance
9.9.4 RD Laboratories Business Overview
9.9.5 RD Laboratories Recent Developments
9.10 West Pharmaceutical Services
9.10.1 West Pharmaceutical Services Biopharmaceutical Testing Services Basic Information
9.10.2 West Pharmaceutical Services Biopharmaceutical Testing Services Product Overview
9.10.3 West Pharmaceutical Services Biopharmaceutical Testing Services Product Market Performance
9.10.4 West Pharmaceutical Services Business Overview
9.10.5 West Pharmaceutical Services Recent Developments
9.11 Polymer Solutions
9.11.1 Polymer Solutions Biopharmaceutical Testing Services Basic Information
9.11.2 Polymer Solutions Biopharmaceutical Testing Services Product Overview
9.11.3 Polymer Solutions Biopharmaceutical Testing Services Product Market Performance
9.11.4 Polymer Solutions Business Overview
9.11.5 Polymer Solutions Recent Developments
9.12 Boston Analytical
9.12.1 Boston Analytical Biopharmaceutical Testing Services Basic Information
9.12.2 Boston Analytical Biopharmaceutical Testing Services Product Overview
9.12.3 Boston Analytical Biopharmaceutical Testing Services Product Market Performance
9.12.4 Boston Analytical Business Overview
9.12.5 Boston Analytical Recent Developments
9.13 Accuratus Labs
9.13.1 Accuratus Labs Biopharmaceutical Testing Services Basic Information
9.13.2 Accuratus Labs Biopharmaceutical Testing Services Product Overview
9.13.3 Accuratus Labs Biopharmaceutical Testing Services Product Market Performance
9.13.4 Accuratus Labs Business Overview
9.13.5 Accuratus Labs Recent Developments
9.14 Microbac
9.14.1 Microbac Biopharmaceutical Testing Services Basic Information
9.14.2 Microbac Biopharmaceutical Testing Services Product Overview
9.14.3 Microbac Biopharmaceutical Testing Services Product Market Performance
9.14.4 Microbac Business Overview
9.14.5 Microbac Recent Developments
9.15 ARLBioPharma
9.15.1 ARLBioPharma Biopharmaceutical Testing Services Basic Information
9.15.2 ARLBioPharma Biopharmaceutical Testing Services Product Overview
9.15.3 ARLBioPharma Biopharmaceutical Testing Services Product Market Performance
9.15.4 ARLBioPharma Business Overview
9.15.5 ARLBioPharma Recent Developments
9.16 Lapuck Laboratories
9.16.1 Lapuck Laboratories Biopharmaceutical Testing Services Basic Information
9.16.2 Lapuck Laboratories Biopharmaceutical Testing Services Product Overview
9.16.3 Lapuck Laboratories Biopharmaceutical Testing Services Product Market Performance
9.16.4 Lapuck Laboratories Business Overview
9.16.5 Lapuck Laboratories Recent Developments
9.17 BioScreen
9.17.1 BioScreen Biopharmaceutical Testing Services Basic Information
9.17.2 BioScreen Biopharmaceutical Testing Services Product Overview
9.17.3 BioScreen Biopharmaceutical Testing Services Product Market Performance
9.17.4 BioScreen Business Overview
9.17.5 BioScreen Recent Developments
10 Biopharmaceutical Testing Services Regional Market Forecast
10.1 Global Biopharmaceutical Testing Services Market Size Forecast
10.2 Global Biopharmaceutical Testing Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biopharmaceutical Testing Services Market Size Forecast by Country
10.2.3 Asia Pacific Biopharmaceutical Testing Services Market Size Forecast by Region
10.2.4 South America Biopharmaceutical Testing Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biopharmaceutical Testing Services by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biopharmaceutical Testing Services Market Forecast by Type (2025-2030)
11.2 Global Biopharmaceutical Testing Services Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings